Correction to: BMC Psychiatry (2018) 18:365
https://doi.org/10.1186/s12888-018-1946-x
Following publication of the original article [1], the authors notified us that the color labelling in Fig. 4 was incorrect.
The corrected Fig. 4 is presented below.
Effects of AOM treatment on Brief Psychiatric Rating Scale (BPRS), global score (values of all items added up) in patients ≤35 years or > 35 years. 18: symptoms not present, 126: symptoms extremely severe. Error bars represent standard deviations
Reference
Schöttle, et al. Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study (2018). 2018;18:365. https://doi.org/10.1186/s12888-018-1946-x.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Schöttle, D., Janetzky, W., Luedecke, D. et al. Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study. BMC Psychiatry 18, 389 (2018). https://doi.org/10.1186/s12888-018-1968-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12888-018-1968-4